LPG SYSTEMS Unveils a Major Advancement: Irradiated Mastectomy Patients Can Benefit From Minimally Invasive Breast Reconstruction
A pilot study published in the Breast Journal shows the benefits of using Endermologie - a trademark of LPG SYSTEMS - in breast reconstruction after mastectomy and radiotherapy.
December 10, 2019
by En-CPhI.CN
Breast Cancer: Hormone Therapy Has a Bigger Impact Than Chemotherapy on Women's Quality of Life - Research by Institut Gustave Roussy
Analysis of the CANTO cohort published in the journal Annals of Oncology will upset received wisdom on the effects that hormone therapy and chemotherapy have on the quality of life in women with breast cancer.
October 10, 2019
by En-CPhI.CN
Study finds onion and garlic consumption may reduce breast cancer risk
Onions and garlic are key ingredients in sofrito, a condiment that's a staple of Puerto Rican cuisine. They may also be a recipe for reducing the risk of breast cancer.
September 24, 2019
by worldpharmanews
Higher Mortality Seen for Male Breast Cancer Patients
Male breast cancer patients have higher mortality after cancer diagnosis than female patients, according to a study published online Sept. 19 in JAMA Oncology.
September 24, 2019
by drugs
Full Chemo Doses May Improve Survival in Breast Cancer
Maintaining full doses of chemotherapy, especially early in the treatment course, is important for survival of intermediate or high-risk breast cancer patients...
September 12, 2019
by drugs
Scientists Find Biological Link Between High Blood Pressure and Breast Cancer
Researchers have identified a protein that may be a risk factor for both high blood pressure and breast cancer.
September 9, 2019
by drugs
USPSTF Advises Meds to Reduce Risk for Primary Breast Cancer
The U.S. Preventive Services Task Force (USPSTF) recommends that clinicians offer risk-reducing medications to women at increased risk for breast cancer and at low risk for adverse medication effects.
September 4, 2019
by drugs
EC approves Roche’s Tecentriq combination to treat breast cancer
Roche has gained approval from the European Commission (EC) for Tecentriq (atezolizumab) with chemotherapy (Abraxane) to treat patients with unresectable locally advanced or...
September 3, 2019
by pharmaceutical-technology
Breast cancer can form 'sleeper cells' after drug treatment
Breast cancer medicines may force some cancer cells into 'sleeper mode', allowing them to potentially come back to life years after initial treatment.
September 3, 2019
by worldpharmanews
Type and Timing of Menopausal HRT Affect Risk of Breast Cancer
Use of menopausal hormone therapy (MHT) is associated with increased incidence of breast cancer, according to a study published online in The Lancet.
September 2, 2019
by drugs
Can Breast Cancer Be a Risk Factor for Opioid Use Among Older Patients?
Dealing with breast cancer is tough, and the depression and anxiety that can come with the diagnosis can up the risk of using opioids while lowering survival rates in older women, a new study finds.
August 28, 2019
by drugs
Men Should Be Included in Breast Cancer Clinical Trials
Men should be included in clinical trials of new breast cancer treatments, the U.S. Food and Drug Administration says.
August 27, 2019
by drugs